No Rights in the Study Drug Sample Clauses

No Rights in the Study Drug. Neither the Institution nor the Investigators, including their employees or agents, shall acquire any rights of any kind whatsoever with respect to the Study Drug or any related Confidential Information as a result of performance under this Agreement or otherwise. No rights granted herein shall restrict Sponsor in the use, manufacture or sales of Study Drug. 9.4
AutoNDA by SimpleDocs
No Rights in the Study Drug. Neither the Institution nor the Investigators, including their employees or agents, shall acquire any rights of any kind whatsoever with respect to the Study Drug or any related Confidential Information as a result of performance under this Agreement or otherwise. No rights granted herein shall restrict Sponsor in the use, manufacture or sales of Study Drug. 9.4 Ž ádná práva na hodnocený lék. Zdravotnické zařízení ani zkoušející, včetně jejich zaměstnanců nebo zástupců, nenabývají žádných práv jakéhokoliv druhu s ohledem na hodnocený lék nebo související důvěrné informace, které jsou výsledkem plnění této smlouvy nebo jiné činnosti. Žádná z práv udělených touto smlouvou neomezují zadavatele v použití, výrobě ani prodeji hodnoceného léku.

Related to No Rights in the Study Drug

  • Research Use The Requester agrees that if access is approved, (1) the PI named in the DAR and (2) those named in the “Senior/Key Person Profile” section of the DAR, including the Information Technology Director and any trainee, employee, or contractor1 working on the proposed research project under the direct oversight of these individuals, shall become Approved Users of the requested dataset(s). Research use will occur solely in connection with the approved research project described in the DAR, which includes a 1-2 paragraph description of the proposed research (i.e., a Research Use Statement). Investigators interested in using Cloud Computing for data storage and analysis must request permission to use Cloud Computing in the DAR and identify the Cloud Service Provider (CSP) or providers and/or Private Cloud System (PCS) that they propose to use. They must also submit a Cloud Computing Use Statement as part of the DAR that describes the type of service and how it will be used to carry out the proposed research as described in the Research Use Statement. If the Approved Users plan to collaborate with investigators outside the Requester, the investigators at each external site must submit an independent DAR using the same project title and Research Use Statement, and if using the cloud, Cloud Computing Use Statement. New uses of these data outside those described in the DAR will require submission of a new DAR; modifications to the research project will require submission of an amendment to this application (e.g., adding or deleting Requester Collaborators from the Requester, adding datasets to an approved project). Access to the requested dataset(s) is granted for a period of one (1) year, with the option to renew access or close-out a project at the end of that year. Submitting Investigator(s), or their collaborators, who provided the data or samples used to generate controlled-access datasets subject to the NIH GDS Policy and who have Institutional Review Board (IRB) approval and who meet any other study specific terms of access, are exempt from the limitation on the scope of the research use as defined in the DAR.

  • Collaboration 31.1 If the Buyer has specified in the Order Form that it requires the Supplier to enter into a Collaboration Agreement, the Supplier must give the Buyer an executed Collaboration Agreement before the Start date.

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Background IP As between the Parties, each Party will retain all right, title and interest in and to all of its Background IP.

  • Patent Rights The State and the U. S. Department of Transportation shall have the royalty free, nonexclusive and irrevocable right to use and to authorize others to use any patents developed by the Engineer under this contract.

  • Research Support opioid abatement research that may include, but is not limited to, the following:

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!